Oral progesterone decreases saccadic eye velocity and increases sedation in women

Psychoneuroendocrinology

Volumn 31, Issue 10, 2006, Pages 1190-1199

  van Broekhoven, F ^a   Backstrom T ^b   Verkes, R J ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UMEÅ UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Allopregnanolone; Behavioural measures; Oral progesterone; Saccadic eye movement; Sedation; Women

Indexed keywords

3ALPHA HYDROXY 5ALPHA PREGNAN 20 ONE; 4 AMINOBUTYRIC ACID; 4 AMINOBUTYRIC ACID A RECEPTOR; DRUG METABOLITE; PLACEBO; PROGESTERONE;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG BLOOD LEVEL; DRUG EFFECT; FEMALE; GABAERGIC SYSTEM; HORMONAL REGULATION; HORMONE METABOLISM; HUMAN; NEUROPHYSIOLOGY; NORMAL HUMAN; PRIORITY JOURNAL; PROGESTERONE BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; RESPONSE TIME; SACCADIC EYE MOVEMENT; SEDATION; TRANQUILIZING ACTIVITY; VISUAL ANALOG SCALE; WOMEN'S HEALTH;

ABSORPTION; ADMINISTRATION, ORAL; ADOLESCENT; ADULT; BEHAVIOR; CONSCIOUS SEDATION; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; FEMALE; HUMANS; HYPNOTICS AND SEDATIVES; PLACEBOS; PREGNANOLONE; PROGESTERONE; SACCADES;

EID: 33751225973     PISSN: 03064530     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.psyneuen.2006.08.007     Document Type: Article

References (26)

1. Andreen L., Spigset O., Andersson A., Nyberg S., and Backstrom T. Pharmacokinetics of progesterone and its metabolites allopregnanolone and pregnanolone after oral administration of low-dose progesterone. Maturitas 54 (2006) 238-244
2. Arafat E.S., Hargrove J.T., Maxson W.S., Desiderio D.M., Wentz A.C., and Andersen R.N. Sedative and hypnotic effects of oral administration of micronized progesterone may be mediated through its metabolites. Am. J. Obstet. Gynecol. 159 (1988) 1203-1209
3. Bond A., and Lader M. The use of analogue scales in rating subjective feelings. Br. J. Psychol. 47 (1974) 211-218
4. de Lignieres B., Dennerstein L., and Backstrom T. Influence of route of administration on progesterone metabolism. Maturitas 21 (1995) 251-257
5. Droogleever Fortuyn H.A., van Broekhoven F., Span P.N., Bäckström T., Zitman F.G., and Verkes R.J. Effects of Ph.D. examination stress on allopregnanolone and cortisol plasma levels and peripheral benzodiazepine receptor density. Psychoneuroendocrinology 29 (2004) 1341-1344
6. Freeman E.W., Purdy R.H., Coutifaris C., Rickels K., and Paul S.M. Anxiolytic metabolites of progesterone: correlation with mood and performance measures following oral progesterone administration to healthy female volunteers. Neuroendocrinology 58 (1993) 478-484
7. Friess, E., Tagaya, E., Trachsel, L., Holsboer, F., Rupprecht, R., 1997. Progesterone-induced changes in sleep in male subjects. Am. J. Physiol. 272 (5 Part 1), E885-E891.
8. Grön G., Friess E., Herpers M., and Rupprecht R. Assessment of cognitive performance after progesterone administration in healthy male volunteers. Neuropsychobiology 35 (1997) 147-151
9. Lancel M., Faulhaber J., Holsboer F., and Rupprecht R. Progesterone induces changes in sleep comparable to those of agonistic GABAA receptor modulators. Am. J. Physiol. 271 4 Part 1 (1996) E763-E772
10. Majewska M.D., Harrison N.L., Schwartz R.D., Barker J.L., and Paul S.M. Steroid hormone metabolites are barbiturate-like modulators of the GABA receptor. Science 232 (1986) 1004-1007
11. Purdy R.H., Moore Jr. P.H., Rao P.N., Hagino N., Yamaguchi T., Schmidt P., Rubinow D.R., Morrow A.L., and Paul S.M. Radioimmunoassay of 3 alpha-hydroxy-5 alpha-pregnan-20-one in rat and human plasma. Steroids 55 (1990) 290-296
12. Purdy R.H., Morrow A.L., Moore Jr. P.H., and Paul S.M. Stress-induced elevations of gamma-aminobutyric acid type A receptor-active steroids in the rat brain. Proc. Natl. Acad. Sci. USA 88 (1991) 4553-4557
13. Schiller P.H., and Tehovnik E.J. Cortical inhibitory circuits in eye-movement generation. Eur. J. Neurosci. 18 (2003) 3127-3133
14. Schiller P.H., and Tehovnik E.J. Neural mechanisms underlying target selection with saccadic eye movements. Prog. Brain Res. 149 (2005) 157-171
15. Soderpalm A.H., Lindsey S., Purdy R.H., Hauger R., and Wit de H. Administration of progesterone produces mild sedative-like effects in men and women. Psychoneuroendocrinology 29 (2004) 339-354
16. Stromstedt M., Warner M., Banner C.D., MacDonald P.C., and Gustafsson J.A. Role of brain cytochrome P450 in regulation of the level of anesthetic steroids in the brain. Mol. Pharmacol. 44 (1993) 1077-1083
17. Timby E., Balgard M., Nyberg S., Spigset O., Andersson A., Porankiewicz-Asplund J., Purdy R.H., Zhu D., Backstrom T., and Poromaa I.S. Pharmacokinetic and behavioral effects of allopregnanolone in healthy women. Psychopharmacology (Berlin) 186 (2006) 414-424
18. Turkmen S., Lundgren P., Birzniece V., Zingmark E., Backstrom T., and Johansson I.M. 3beta-20beta-dihydroxy-5alpha-pregnane (UC1011) antagonism of the GABA potentiation and the learning impairment induced in rats by allopregnanolone. Eur. J. Neurosci. 20 (2004) 1604-1612
19. van Broekhoven F., and Verkes R.J. Neurosteroids in depression: a review. Psychopharmacology (Berlin) 165 (2003) 97-110
20. van Steveninck A.L., van Berckel B.N., Schoemaker R.C., Breimer D.D., van Gerven J.M., and Cohen A.F. The sensitivity of pharmacodynamic tests for the central nervous system effects of drugs on the effects of sleep deprivation. J. Psychopharmacol. 13 (1999) 10-17
21. Vanselow W., Dennerstein L., Greenwood K.M., and de Lignieres B. Effect of progesterone and its 5 alpha and 5 beta metabolites on symptoms of premenstrual syndrome according to route of administration. J. Psychosom. Obstet. Gynaecol. 17 (1996) 29-38
22. Wang M.D., Wahlstrom G., Gee K.W., and Backstrom T. Potency of lipid and protein formulation of 5 alpha-pregnanolone at induction of anaesthesia and the corresponding regional brain distribution. Br. J. Anaesth. 74 (1995) 553-557
23. Wang M.D., Seippel L., Purdy R.H., and Backstrom T. Relationship between symptom severity and steroid variation in women with premenstrual syndrome: study on serum pregnenolone, pregnenolone sulfate, 5 alpha-pregnane-3,20-dione and 3 alpha-hydroxy-5 alpha-pregnan-20-one. J. Clin. Endocrinol. Metab. 81 (1996) 1076-1082
24. Wieland S., Lan N.C., Mirasedeghi S., and Gee K.W. Anxiolytic activity of the progesterone metabolite 5 alpha-pregnan-3 alpha-o1-20-one. Brain Res. 565 (1991) 263-268
25. Wirth M.M., Meier E.A., Fredrickson B.L., and Schultheiss O.C. Relationship between salivary cortisol and progesterone levels in humans. Biol. Psychol. Aug. 10 (2006) (Epub ahead of print)
26. Zhu D., Birzniece V., Backstrom T., and Wahlstrom G. Dynamic aspects of acute tolerance to allopregnanolone evaluated using anaesthesia threshold in male rats. Br. J. Anaesth. 93 (2004) 560-567